Format
Sort by
Items per page

Send to

Choose Destination

Selected items

Items: 20

1.

Using antipsychotic agents in older patients.

Alexopoulos GS, Streim J, Carpenter D, Docherty JP; Expert Consensus Panel for Using Antipsychotic Drugs in Older Patients..

J Clin Psychiatry. 2004;65 Suppl 2:5-99; discussion 100-102; quiz 103-4. Review.

2.

Antipsychotic agents in the treatment of anorexia nervosa: neuropsychopharmacologic rationale and evidence from controlled trials.

Brewerton TD.

Curr Psychiatry Rep. 2012 Aug;14(4):398-405. doi: 10.1007/s11920-012-0287-6. Review.

PMID:
22628000
3.

Risk of falls and fractures in older adults using atypical antipsychotic agents: a propensity score-adjusted, retrospective cohort study.

Chatterjee S, Chen H, Johnson ML, Aparasu RR.

Am J Geriatr Pharmacother. 2012 Apr;10(2):83-94. doi: 10.1016/j.amjopharm.2011.10.006. Epub 2012 Feb 10.

PMID:
22306198
4.

A long-term trial of the effectiveness and safety of atypical antipsychotic agents in augmenting SSRI-refractory obsessive-compulsive disorder.

Matsunaga H, Nagata T, Hayashida K, Ohya K, Kiriike N, Stein DJ.

J Clin Psychiatry. 2009 Jun;70(6):863-8. doi: 10.4088/JCP.08m04369. Epub 2009 May 5.

PMID:
19422759
5.

Second-generation long-acting injectable antipsychotic agents: an overview.

[No authors listed]

Drug Ther Bull. 2012 Sep;50(9):102-5. doi: 10.1136/dtb.2012.08.0127. Review.

PMID:
22966099
6.
7.
8.

A randomized evaluation of the effects of six antipsychotic agents on QTc, in the absence and presence of metabolic inhibition.

Harrigan EP, Miceli JJ, Anziano R, Watsky E, Reeves KR, Cutler NR, Sramek J, Shiovitz T, Middle M.

J Clin Psychopharmacol. 2004 Feb;24(1):62-9.

PMID:
14709949
9.

The effect of metformin on anthropometrics and insulin resistance in patients receiving atypical antipsychotic agents: a meta-analysis.

Ehret M, Goethe J, Lanosa M, Coleman CI.

J Clin Psychiatry. 2010 Oct;71(10):1286-92. doi: 10.4088/JCP.09m05274yel. Epub 2010 Apr 6.

PMID:
20441727
10.

Prevalence of the metabolic syndrome in schizophrenic patients receiving second-generation antipsychotic agents--a cross-sectional study.

Kagal UA, Torgal SS, Patil NM, Malleshappa A.

J Pharm Pract. 2012 Jun;25(3):368-73. doi: 10.1177/0897190012442220. Epub 2012 May 2.

PMID:
22551560
11.

Cost effectiveness of long-acting risperidone injection versus alternative antipsychotic agents in patients with schizophrenia in the USA.

Edwards NC, Locklear JC, Rupnow MF, Diamond RJ.

Pharmacoeconomics. 2005;23 Suppl 1:75-89.

PMID:
16416763
12.

[Antipsychotic agents in the treatment of somatoform disorders; a review].

Decoutere L, van den Eede F, Moorkens G, Sabbe BG.

Tijdschr Psychiatr. 2011;53(3):163-73. Review. Dutch.

13.
14.

Newer oral atypical antipsychotic agents: a review.

Scarff JR, Casey DA.

P T. 2011 Dec;36(12):832-8. No abstract available.

15.

[The syndrome of inappropriate antidiuretic hormone secretion (SIADH) during treatment with the antipsychotic agents haloperidol and quetiapine].

van den Heuvel OA, Bet PM, van Dam EW, Eeckhout AM.

Ned Tijdschr Geneeskd. 2006 Sep 2;150(35):1944-8. Dutch.

PMID:
16999280
16.

Atypical antipsychotic agents in the treatment of violent patients with schizophrenia and schizoaffective disorder.

Krakowski MI, Czobor P, Citrome L, Bark N, Cooper TB.

Arch Gen Psychiatry. 2006 Jun;63(6):622-9.

PMID:
16754835
17.

The association between antipsychotic agents and the risk of myocardial infarction: a systematic review.

Brauer R, Douglas I, Smeeth L.

Br J Clin Pharmacol. 2011 Dec;72(6):871-8. doi: 10.1111/j.1365-2125.2011.04043.x. Review.

18.

Risk of serious cardiac events in older adults using antipsychotic agents.

Mehta S, Chen H, Johnson M, Aparasu RR.

Am J Geriatr Pharmacother. 2011 Apr;9(2):120-32. doi: 10.1016/j.amjopharm.2011.03.004.

PMID:
21565711
19.

Venous thromboembolism among elderly patients treated with atypical and conventional antipsychotic agents.

Liperoti R, Pedone C, Lapane KL, Mor V, Bernabei R, Gambassi G.

Arch Intern Med. 2005 Dec 12-26;165(22):2677-82.

PMID:
16344428
20.

Glucose metabolism in patients with schizophrenia treated with atypical antipsychotic agents: a frequently sampled intravenous glucose tolerance test and minimal model analysis.

Henderson DC, Cagliero E, Copeland PM, Borba CP, Evins E, Hayden D, Weber MT, Anderson EJ, Allison DB, Daley TB, Schoenfeld D, Goff DC.

Arch Gen Psychiatry. 2005 Jan;62(1):19-28.

PMID:
15630069

Supplemental Content

Support Center